{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:41Z","timestamp":1792787801264,"version":"4.5.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funding Programme for Next Generation World-Leading Researchers of JSPS","award":["LS088"],"award-info":[{"award-number":["LS088"]}]},{"name":"Grant-in-Aid for Scientific Research on Innovative Areas of MEXT","award":["JP23111008"],"award-info":[{"award-number":["JP23111008"]}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012029","name":"Tsuchiya Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Both fragile X-associated tremor\/ataxia syndrome (FXTAS) and late-onset neuronal intranuclear inclusion disease (NIID) show CGG\/GGC trinucleotide repeat expansions. Differentiating these diseases are difficult because of the similarity in their clinical and radiological features. It is unclear that skin biopsy can distinguish NIID from FXTAS. We performed a skin biopsy in an FXTAS case with cognitive dysfunction and peripheral neuropathy without tremor, which was initially suspected to be NIID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      The patient underwent neurological assessment and examinations, including laboratory tests, electrophysiologic test, imaging, skin biopsy, and genetic test. A brain MRI showed hyperintensity lesions along the corticomedullary junction on diffusion-weighted imaging (DWI) in addition to middle cerebellar peduncle sign (MCP sign). We suspected NIID from the clinical picture and the radiological findings, and performed a skin biopsy. The skin biopsy specimen showed ubiquitin- and p62-positive intranuclear inclusions, suggesting NIID. However, a genetic analysis for NIID using repeat-primed polymerase chain reaction (RP-PCR) revealed no expansion detected in the\n                      <jats:italic>Notch 2\u2009N-terminal like C<\/jats:italic>\n                      (\n                      <jats:italic>NOTCH2NLC<\/jats:italic>\n                      ) gene\n                      <jats:italic>.<\/jats:italic>\n                      We then performed genetic analysis for FXTAS using RP-PCR, which revealed a repeat CGG\/GGC expansion in the\n                      <jats:italic>FMRP translational regulator 1<\/jats:italic>\n                      (\n                      <jats:italic>FMR1<\/jats:italic>\n                      ) gene. The number of repeats was 83. We finally diagnosed the patient with FXTAS rather than NIID.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For the differential diagnosis of FXTAS and NIID, a skin biopsy alone is insufficient; instead, genetic analysis, is essential. Further investigations in additional cases based on genetic analysis are needed to elucidate the clinical and pathological differences between FXTAS and NIID.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02425-z","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T21:07:06Z","timestamp":1634072826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Megumi","family":"Toko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3915-2963","authenticated-orcid":false,"given":"Tomohiko","family":"Ohshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kurashige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideshi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"2425_CR1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","volume":"57","author":"MA Leehey","year":"2009","unstructured":"Leehey MA. Fragile X-associated tremor\/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med. 2009;57:830\u20136.","journal-title":"J Investig Med"},{"key":"2425_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41588-019-0459-y","volume":"51","author":"J Sone","year":"2019","unstructured":"Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, et al. Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 2019;51:1215\u201321.","journal-title":"Nat Genet"},{"key":"2425_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jnnp-2013-306084","volume":"85","author":"J Sone","year":"2014","unstructured":"Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H, et al. Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry. 2014;85:354\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2425_CR4","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/brain\/aww249","volume":"139","author":"J Sone","year":"2016","unstructured":"Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, et al. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016;139:3170\u201386.","journal-title":"Brain."},{"key":"2425_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/00125817-200105000-00010","volume":"3","author":"A Maddalena","year":"2001","unstructured":"Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the standards and guidelines for clinical genetics Laboratories of the American College of medical genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med. 2001;3:200\u20135.","journal-title":"Genet Med"},{"key":"2425_CR6","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/s41588-019-0458-z","volume":"51","author":"H Ishiura","year":"2019","unstructured":"Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019;51:1222\u201332.","journal-title":"Nat Genet"},{"key":"2425_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1440-1789.2008.00948.x","volume":"29","author":"M Gokden","year":"2009","unstructured":"Gokden M, Al-Hinti JT, Harik SI. Peripheral nervous system pathology in fragile X tremor\/ataxia syndrome (FXTAS). Neuropathology. 2009;29:280\u20134.","journal-title":"Neuropathology."},{"key":"2425_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00401-011-0860-9","volume":"122","author":"MR Hunsaker","year":"2011","unstructured":"Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F, et al. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor\/ataxia syndrome and CGG knock-in mice. Acta Neuropathol. 2011;122:467\u201379.","journal-title":"Acta Neuropathol"},{"key":"2425_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01954","volume":"5","author":"G Bonapace","year":"2019","unstructured":"Bonapace G, Gullace R, Concolino D, Iannello G, Procopio R, Gagliardi M, et al. Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome. Heliyon. 2019;5:e01954.","journal-title":"Heliyon."}],"updated-by":[{"DOI":"10.1186\/s12883-021-02452-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000}}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02425-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T09:06:17Z","timestamp":1635325577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02425-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2425"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02425-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12883-021-02452-w","URL":"https:\/\/doi.org\/10.1186\/s12883-021-02452-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional review Boards of Hiroshima University. (Hi-43\u201325), and the patient gave written informed consent prior to obtain the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}